2024 Symposium Abstracts: The Promise of PRRT in Neuroendocrine Tumor Treatment

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/08/77/ed/0877eda4-cbb1-bace-3644-e73fb7aced4f/mza_1512576652754283542.jpeg/600x600bb.jpg

NETCast

Podcasting4Associations

37 episodes

2 months ago

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more.

Visit us at

All content for NETCast is the property of Podcasting4Associations and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Visit us at

2024 Symposium Abstracts: The Promise of PRRT in Neuroendocrine Tumor Treatment - Recorded November 22nd, 2024

NETCast

44 minutes 50 seconds

9 months ago

2024 Symposium Abstracts: The Promise of PRRT in Neuroendocrine Tumor Treatment - Recorded November 22nd, 2024

In this episode of NETCAST, neuroendocrine experts Dr. Mosalem and Dr. Wahl meet with Taymeyah Al-Toubah discuss the latest advancements in neuroendocrine tumor treatments, focusing on peptide receptor radionuclide therapy (PRRT) with alpha and beta emitters. They delve into the safety and efficacy of new investigational agents, the challenges of hematological toxicity, and the importance of multidisciplinary teams in managing patient care. The conversation highlights the evolving landscape of neuroendocrine tumor therapies and the need for ongoing research and collaboration. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.